Vest Financial LLC Purchases 2,383 Shares of Chemed Corporation $CHE

Vest Financial LLC increased its position in shares of Chemed Corporation (NYSE:CHE) by 32.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,702 shares of the company’s stock after buying an additional 2,383 shares during the period. Vest Financial LLC owned about 0.07% of Chemed worth $4,344,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in CHE. Geneos Wealth Management Inc. raised its holdings in shares of Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in Chemed by 59.7% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 2,389 shares of the company’s stock worth $1,130,000 after acquiring an additional 893 shares in the last quarter. Farther Finance Advisors LLC grew its position in Chemed by 148.0% during the 2nd quarter. Farther Finance Advisors LLC now owns 372 shares of the company’s stock worth $181,000 after purchasing an additional 222 shares during the last quarter. Fortune Financial Advisors LLC increased its position in shares of Chemed by 47.7% in the 2nd quarter. Fortune Financial Advisors LLC now owns 1,603 shares of the company’s stock valued at $781,000 after acquiring an additional 518 shares during the period. Finally, MBE Wealth Management LLC raised its stake in shares of Chemed by 9.0% in the second quarter. MBE Wealth Management LLC now owns 592 shares of the company’s stock worth $288,000 after purchasing an additional 49 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total value of $875,100.00. Following the sale, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 3.29% of the stock is currently owned by company insiders.

Chemed Stock Performance

Shares of NYSE CHE opened at $453.27 on Thursday. The firm has a fifty day moving average of $436.21 and a 200 day moving average of $443.61. The firm has a market cap of $6.42 billion, a PE ratio of 23.97, a PEG ratio of 2.19 and a beta of 0.44. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Tuesday, October 28th. The company reported $5.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.39 by ($0.12). The company had revenue of $624.90 million for the quarter, compared to analysts’ expectations of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the business earned $5.64 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, equities analysts predict that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Monday, November 17th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, November 17th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio is presently 12.69%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a report on Wednesday, October 8th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Royal Bank Of Canada decreased their target price on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research note on Monday, November 10th. Finally, Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $555.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.